Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Hypoglycemia/chemically induced"'
Autor:
Molveau, Joséphine, Rabasa-Lhoret, Rémi, Myette-Côté, Étienne, Messier, Virginie, Suppère, Corinne, J Potter, Kathryn, Heyman, Elsa, Tagougui, Sémah
Publikováno v:
Frontiers in Endocrinology
Frontiers in Endocrinology, 2022, Frontiers in Endocrinology, 13, pp.953879. ⟨10.3389/fendo.2022.953879⟩
Frontiers in Endocrinology, 2022, Frontiers in Endocrinology, 13, pp.953879. ⟨10.3389/fendo.2022.953879⟩
ObjectiveStudies investigating strategies to limit the risk of nocturnal hypoglycemia associated with physical activity (PA) are scarce and have been conducted in standardized, controlled conditions in people with type 1 diabetes (T1D). This study so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a66c844970ee38e48f738d981f924fb
http://hdl.handle.net/20.500.12210/79296
http://hdl.handle.net/20.500.12210/79296
Publikováno v:
Revue medicale suisse, vol. 17, no. 741, pp. 1078-1082
Insulin therapy, often initiated after hygiene and dietary measures and non-insulin antidiabetics, is part of the treatment of patients with type 2 diabetes. Fear of injections or hypoglycemia often delays its implementation. However, its introductio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::9b7b8367f3e395ca375e09312197620a
https://serval.unil.ch/resource/serval:BIB_52AF0A9A103F.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_52AF0A9A103F.P001/REF.pdf
Autor:
Christoph Engel, Konrad Reinhart, Andreas Meier-Hellmann, Max Ragaller, Frank Bloos, Charles Natanson, Rolf Rossaint, Onnen Moerer, Stefan John, Matthias Gruendling, Martin Schaefer, Norbert Weiler, Christiane S. Hartog, Tobias Welte, Frank M. Brunkhorst, Markus Loeffler, Ulrich Jaschinski, Stefan Grond, Peter M. Kern, Michael Oppert, Derk Olthoff, Michael Kiehntopf, Evelyn Kuhnt
BACKGROUND: The role of intensive insulin therapy in patients with severe sepsis is uncertain. Fluid resuscitation improves survival among patients with septic shock, but evidence is lacking to support the choice of either crystalloids or colloids. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b0e8bcd00a1b3dc959334af512d3eb6
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/81967
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/81967
Autor:
Petrie, John R., Chaturvedi, Nish, Ford, Ian, Hramiak, Irene, Hughes, Alun D., Jenkins, Alicia J., E. Klein, Barbara, Klein, Ron, Ooi, Teik Chye, Rossing, Peter, Sattar, Naveed, Stehouwer, Coen D. A., Colhoun, Helen M., Ford, I, Kean, S, Thomson, E, Gillespie, L, Gibb, J, Greenlaw, N, Hramiak, I, Keech, A, Jenkins, A, Chaturvedi, N, Hughes, A, March, K, Coady, E, Tillin, T, Bots, M, Klein, R, Klein, B, Dreyer, J, Jan, T, Meuer, S, Murach, D, Sheffy, Koby, Lusky, Ravit, Peleg, S, Petrie, J, Colhoun, H, Shore, A, Carty, D, Donnan, P, Witham, M, Adler, A, Lonn, E, Rauchhaus, P, Lindsay, R, Brouwers, M, Van‐Melckebeke, J, Hamill, T, Cuthbertson, L, Murray, A, Jolly, L, Miller, E, Sattar, N, Hair, J, Bell, A, Carmichael, S, Douglas, E, Surtees, P, Dinnett, E, Allan, J, Watson, C, McLaughlin, M, Brindley, G, Smillie, E, Motherwell, D, MacDonald, S, Ellis, P, Stuart, D, Travers, M, Brearley, S, Greig, L, Haw, J
Publikováno v:
Petrie, J R, Chaturvedi, N, Ford, I, Hramiak, I, Hughes, A D, Jenkins, A J, E Klein, B, Klein, R, Ooi, T C, Rossing, P, Sattar, N, Stehouwer, C D A, Colhoun, H M & REMOVAL Trial Team 2017, ' Metformin in adults with type 1 diabetes : Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial ', Diabetes, Obesity and Metabolism, vol. 19, no. 4, pp. 509-516 . https://doi.org/10.1111/dom.12840
Diabetes, Obesity & Metabolism, 19(4), 509. Wiley-Blackwell
2017, ' Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial ', Diabetes, Obesity and Metabolism, vol. 19, no. 4 . https://doi.org/10.1111/dom.12840
Diabetes, Obesity & Metabolism
Diabetes Obesity & Metabolism, 19(4), 509-516. Wiley
Diabetes, Obesity & Metabolism, 19(4), 509. Wiley-Blackwell
2017, ' Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial ', Diabetes, Obesity and Metabolism, vol. 19, no. 4 . https://doi.org/10.1111/dom.12840
Diabetes, Obesity & Metabolism
Diabetes Obesity & Metabolism, 19(4), 509-516. Wiley
Aims: Cardiovascular (CV) disease is a major cause of reduced life expectancy in type 1 diabetes (T1D). Intensive insulin therapy prevents CV complications but is constrained by hypoglycaemia and weight gain. Adjunct metformin reduces insulin dose re
Autor:
Amra Ciric Alibegovic, Henning Beck-Nielsen, Henrik U. Andersen, Ulrik Pedersen-Bjergaard, Birger Thorsteinsson, Peter Gustenhoff, Troels Krarup Hansen, Kirsten Nørgaard, Claus B. Juhl, Tonny Jensen, Christoffer Hedetoft, Lise Tarnow, Rikke Mette Agesen, Susanne Lerche, Hans-Henrik Parving
Publikováno v:
BMC Endocrine Disorders
BMC Endocrine Disorders, Vol 19, Iss 1, Pp 1-8 (2019)
Agesen, R M, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C, Jensen, T, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2019, ' The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial) : study rationale and design ', BMC Endocrine Disorders, vol. 19, no. 1, 78 . https://doi.org/10.1186/s12902-019-0408-x
Agesen, R M, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C, Jensen, T, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Thorsteinsson, B, Pedersen-Bjergaard, U & Bariatri og Diabetes 2019, ' The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial) : study rationale and design ', BMC Endocrine Disorders, vol. 19, 78 . https://doi.org/10.1186/s12902-019-0408-x
Agesen, R M, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C, Jensen, T, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2019, ' The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial) : study rationale and design ', BMC Endocrine Disorders, vol. 19, 78 . https://doi.org/10.1186/s12902-019-0408-x
Agesen, R M, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C, Jensen, T, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2019, ' The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design ', BMC Endocrine Disorders, vol. 19, 78, pp. 1-8 . https://doi.org/10.1186/s12902-019-0408-x
BMC Endocrine Disorders, Vol 19, Iss 1, Pp 1-8 (2019)
Agesen, R M, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C, Jensen, T, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2019, ' The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial) : study rationale and design ', BMC Endocrine Disorders, vol. 19, no. 1, 78 . https://doi.org/10.1186/s12902-019-0408-x
Agesen, R M, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C, Jensen, T, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Thorsteinsson, B, Pedersen-Bjergaard, U & Bariatri og Diabetes 2019, ' The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial) : study rationale and design ', BMC Endocrine Disorders, vol. 19, 78 . https://doi.org/10.1186/s12902-019-0408-x
Agesen, R M, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C, Jensen, T, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2019, ' The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial) : study rationale and design ', BMC Endocrine Disorders, vol. 19, 78 . https://doi.org/10.1186/s12902-019-0408-x
Agesen, R M, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C, Jensen, T, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2019, ' The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design ', BMC Endocrine Disorders, vol. 19, 78, pp. 1-8 . https://doi.org/10.1186/s12902-019-0408-x
BACKGROUND: Hypoglycaemia, especially nocturnal, remains the main limiting factor of achieving good glycaemic control in type 1 diabetes. The effect of first generation long-acting insulin analogues in reducing nocturnal hypoglycaemia is well documen
Autor:
Chantal, Mathieu, Paresh, Dandona, Pieter, Gillard, Peter, Senior, Christoph, Hasslacher, Eiichi, Araki, Marcus, Lind, Stephen C, Bain, Serge, Jabbour, Niki, Arya, Lars, Hansen, Fredrik, Thorén, Anna Maria, Langkilde, Shichun, Bao
Publikováno v:
Diabetes care. 41(9)
OBJECTIVE This 24-week, double-blinded, phase 3 clinical trial (DEPICT-2; ClinicalTrials.gov, NCT02460978) evaluated efficacy and safety of dapagliflozin as adjunct therapy to adjustable insulin in patients with inadequately controlled type 1 diabete
Autor:
E.G.A.H. van Mil, Esther Hartman, Christel Hendrieckx, Jane Speight, Henk-Jan Aanstoot, Anke M. Nieuwesteeg, Per Winterdijk, Giesje Nefs, Frans Pouwer, Jori Aalders
Publikováno v:
Diabetic Medicine, 35, 5, pp. 650-657
Diabetic Medicine: Journal of the British Diabetic Association, 35(5), 650-657. Wiley-Blackwell
Aalders, J, Hartman, E, Nefs, G, Nieuwesteeg, A, Hendrieckx, C, Aanstoot, H J, Winterdijk, P, van Mil, E, Speight, J & Pouwer, F 2018, ' Mindfulness and fear of hypoglycaemia in parents of children with Type 1 diabetes : Results from Diabetes MILES Youth-The Netherlands ', Diabetic Medicine, vol. 35, no. 5, pp. 650-657 . https://doi.org/10.1111/dme.13594
Diabetic Medicine, 35(5), 650-657. Wiley
Diabetic Medicine
Diabetic Medicine, 35, 650-657
Diabetic Medicine: Journal of the British Diabetic Association, 35(5), 650-657. Wiley-Blackwell
Aalders, J, Hartman, E, Nefs, G, Nieuwesteeg, A, Hendrieckx, C, Aanstoot, H J, Winterdijk, P, van Mil, E, Speight, J & Pouwer, F 2018, ' Mindfulness and fear of hypoglycaemia in parents of children with Type 1 diabetes : Results from Diabetes MILES Youth-The Netherlands ', Diabetic Medicine, vol. 35, no. 5, pp. 650-657 . https://doi.org/10.1111/dme.13594
Diabetic Medicine, 35(5), 650-657. Wiley
Diabetic Medicine
Diabetic Medicine, 35, 650-657
Aims To identify the sociodemographic and clinical correlates of fear of hypoglycaemia among parents of children (aged 4–18 years) with Type 1 diabetes and to examine the relationships between parental fear of hypoglycaemia, mindfulness and mindful
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2e80fcf547af80dbcb4508ac32f5f5f
https://hdl.handle.net/2066/191063
https://hdl.handle.net/2066/191063
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Peter Kristensen, Lise Tarnow, Kirsten Nørgaard, Birger Thorsteinsson, H. H. Parving, Jens Sandahl Christiansen, Tonny Jensen, Hans Perrild, Henning Beck-Nielsen, Ulrik Pedersen-Bjergaard, Christiane Bay
Publikováno v:
Kristensen, P L, Tarnow, L, Bay, C, Nørgaard, K, Jensen, T, Parving, H-H, Perrild, H, Beck-Nielsen, H, Christiansen, J S, Thorsteinsson, B & Pedersen-Bjergaard, U 2017, ' Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia-prone people with Type 1 diabetes ', Diabetic Medicine, vol. 34, no. 5, pp. 625-631 . https://doi.org/10.1111/dme.13317
Kristensen, P L, Tarnow, L, Bay, C, Nørgaard, K, Jensen, T, Parving, H-H, Perrild, H, Beck-Nielsen, H, Christiansen, J S, Thorsteinsson, B & Pedersen-Bjergaard, U 2017, ' Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia-prone people with Type 1 diabetes ', Diabetic Medicine, vol. 34, no. 5, pp. 625–631 . https://doi.org/10.1111/dme.13317
Kristensen, P L, Tarnow, L, Bay, C, Nørgaard, K, Jensen, T, Parving, H-H, Perrild, H, Beck-Nielsen, H, Christiansen, J S, Thorsteinsson, B & Pedersen-Bjergaard, U 2017, ' Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia-prone people with Type 1 diabetes ', Diabetic Medicine, vol. 34, no. 5, pp. 625–631 . https://doi.org/10.1111/dme.13317
AIMS: To assess the difference between analogue and human insulin with regard to nocturnal glucose profiles and risk of hypoglycaemia in people with recurrent severe hypoglycaemia.METHODS: A total of 72 people [46 men, mean ± sd age 54 ± 12 years,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::730529f2cf78cba78dcfe55b46283873
https://pure.au.dk/portal/da/publications/comparing-effects-of-insulin-analogues-and-human-insulin-on-nocturnal-glycaemia-in-hypoglycaemiaprone-people-with-type-1-diabetes(ffd83a85-532f-451c-81db-8884abb4f3fe).html
https://pure.au.dk/portal/da/publications/comparing-effects-of-insulin-analogues-and-human-insulin-on-nocturnal-glycaemia-in-hypoglycaemiaprone-people-with-type-1-diabetes(ffd83a85-532f-451c-81db-8884abb4f3fe).html
Publikováno v:
Revue médicale suisse, Vol. 13, No 565 (2017) pp. 1140-1144
Management of type 1 and type 2 diabetes mellitus is getting complex with the apparition of new treatments, but also new technologies. Among these, continuous glucose monitoring systems (CGMS) lead to a better glycemic control and less hypoglycemia i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c38966314778e729108edb340b933ae2
https://archive-ouverte.unige.ch/unige:109617
https://archive-ouverte.unige.ch/unige:109617